Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network.
about
A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40.Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma.CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
P2860
Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Update on the molecular pathog ...... Mantle Cell Lymphoma Network.
@en
Update on the molecular pathog ...... Mantle Cell Lymphoma Network.
@nl
type
label
Update on the molecular pathog ...... Mantle Cell Lymphoma Network.
@en
Update on the molecular pathog ...... Mantle Cell Lymphoma Network.
@nl
prefLabel
Update on the molecular pathog ...... Mantle Cell Lymphoma Network.
@en
Update on the molecular pathog ...... Mantle Cell Lymphoma Network.
@nl
P2093
P2860
P1433
P1476
Update on the molecular pathog ...... n Mantle Cell Lymphoma Network
@en
P2093
Christiane Pott
European Mantle Cell Lymphoma Network
Martin Dreyling
Mary Callanan
Mats Jerkeman
Simon Rule
Steven Le Gouill
Virginia Amador
P2860
P304
P356
10.3109/10428194.2014.940584
P577
2014-08-20T00:00:00Z